FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

List of news

Clinical evaluation of Sysmex Inostics’ plasma NGS liquid biopsy technology to complement mammography when screening for early stage breast cancer presented at the 2018 ASCO annual meeting CytoCell et autres Oxford Gene Technology produits chez Sysmex CytoCell und weitere Oxford Gene Technology Produkte bei Sysmex erhältlich NIET BEREIKBAAR - wegens onderhoud Die neue Ausgabe unseres Kundenmagazins Xtra ist da! Nouveau slogan Sysmex “Lighting the way with diagnostics” Neuer Sysmex Slogan "Lighting the way with diagnostics" Neuer Sysmex Slogan “Lighting the way with diagnostics” II Международный междисциплинарный научно-практический Форум-выставка «ЛАБОРАТОРНАЯ МЕДИЦИНА: СОВРЕМЕННЫЕ ТЕХНОЛОГИИ И ДИАГНОСТИКА» Школа Гематолога в Перми Bundestagsabgeordnete besucht Sysmex in Norderstedt «Конференция для специалистов лабораторной службы Липецкой области» Школа гемостаза в Ростове-на-Дону Sysmex feiert 50-jähriges Jubiläum Sysmex feiert 50-jähriges Jubiläum Sysmex feiert 50-jähriges Jubiläum Sysmex Middle East in Medlab exhibition 5-8 February 2018 in Dubai- UAE мероприятие IV Медицинский форум «Актуальные вопросы совершенствования медицинской помощи. Ильменские встречи» Школа Гемостаза «Тромботические и геморрагические осложнения в акушерстве, гинекологии и неонатологии» Podrobná zpráva: Porovnání výkonu testů likvidní biopsie OncoBEAM RAS CRC a Idylla ctKRAS prezentované na konferenci ASCO GI 2018 Nový e-shop protilátek Leistungsvergleich der Liquid Biopsy-Verfahren OncoBEAM RAS CRC und Idylla ctKRAS zum Nachweis von KRAS-Mutationen auf der ASCO-GI-Konferenz 2018 vorgestellt In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018 In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018
Sysmex XN – TAILORING YOUR HAEMATOLOGY
See the scalability of XN
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
See our collection
Sysmex XN – TAILORING YOUR HAEMATOLOGY
See the scalability of XN